Japanese Red Cross Kumamoto Hospital /ID# 268586

Kumamoto, Kumamoto 861-8520

1 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease — Recruiting now